December 11, 2024
The American Diabetes Association (ADA)’s Standards of Care — 2025 offer new guidance on broader use of continuous glucose monitoring (CGM), use of glucagon-like peptide 1 […]
December 9, 2024
TOPLINE: Bone material strength index (BMSi) values remain low in patients with Cushing syndrome even after 6 years in remission, despite having comparable bone mineral density […]
December 9, 2024
TOPLINE: Increased cutaneous carbonyl stress is linked to slower nerve conduction in patients with metabolically well-controlled, recent-onset type 2 diabetes (T2D) and can predict the development […]
December 6, 2024
TOPLINE: International paediatric type 1 diabetes (T1D) registry data show improvement from 2013 to 2022 in average A1c and the proportion of children with T1D meeting […]
December 6, 2024
TOPLINE: People with type 2 diabetes (T2D) die from infections at a higher rate than similar people without diabetes, and the overall burden appears greater than […]
December 6, 2024
TOPLINE: Patients treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) appear to have a very low incidence of nonarteritic anterior ischemic optic neuropathy (NAION) when […]
December 5, 2024
TOPLINE: Consuming five or more servings per week of dark chocolate is associated with a lower risk for type 2 diabetes (T2D) compared with infrequent or […]
December 5, 2024
Glucagon-like peptide 1 receptor agonist (GLP-1) prescriptions for diabetes and obesity treatment are soaring, as is the interest in their potential for treating an array of […]
December 5, 2024
Endocrine disruptors (EDs) — chemicals in the environment that could affect human endocrine function — are increasingly becoming a prominent concern for the public as well […]